Antibody (2)
Launched (2)
Mouse (2)
- (2)
Unconjugated (2)
| Cat. No. | Species | Host | Product Description | Structure | Purity | Feature | Order Now |
|---|---|---|---|---|---|---|---|
GL2-MY2094 | HEK293 | Monoclonal Anti-Rubella virus Glycoprotein E2 & E1 Antibody, Human IgG1 (3E2) (MALS verified) | |||||
GL2-MY2095 | HEK293 | Monoclonal Anti-Rubella virus Glycoprotein E2 & E1 Antibody, Human IgG1 (4D1) (MALS verified) |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| AS-1501 | AS-1501 | Phase 1 Clinical | Shenzhen Zhongke Ai Shen Pharmaceutical Co Ltd | Liver Failure; Hepatitis; Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injury, Chronic; Hepatic Insufficiency | Details |

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521
[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland



